University of Hawaii | Cancer Center | Graduate Programs | Undergraduates | UHResearch | UHDirectory

 

University of Hawaii Cancer Center

Cancer Biology Program

University of Hawai'i at Manoa
701 ILALO Street, Room 443 
Honolulu, Hawai'i  96813

Office: (808) 564-5843 Lab: (808) 440-5236

Home |  Research Interests  |  Publications  |  Personnel  |  Courses  |  Links

joeOur mission is to understand the underlying mechanisms that control cancer cell metastasis. We are particularly focused on the role of RSK2 and PEA-15 in complex with ERK MAP kinase in cancer cell invasion and migration. More recently our work has extended to the function of RasGRP1 in skin cancer. In collaboration with Chemists in the Natural Products and Experimental Therapeutics program we are developing new drugs to target cancer based on our basic research findings. Currently we are investigating the dysregulation of cell signalling in skin cancer, renal cancers, neuroblastoma and glioblastoma.

Funding for our research has been provided by The National Institutes of Health, the Department of Defense, the Hawaii Community Foundation and the Friends of the Cancer Research Center among others. Here you can get acquainted with our work through our publications and statement of research interests.  In addition, take a moment to note who is in the lab and some of our collaborators. Our lab is on the beautiful island of Oahu and you can find directions to us here. Thanks for visiting!

AfCS
NCBI
Pubmed
Blast
Library
Sequencing Core
EHSO

ORS

UH Map
Lab Photos
Lab Calendar

Joe W. Ramos, Ph.D.
Professor
Program Director, Cancer Biology


mailE-mail: jramos@cc.hawaii.edu


Facebook Flickr
NEWS

See Florian and Joe's review of RSK function in metastasis in Cancer Research.

lab folk
Amrish shows the importance of RasGRP1 function in squamous cell carcinoma (skin cancer) in his recent paper in Carcinogenesis.

Asia and Shirley report in JBC that RSK2 can promote cancer cell migration through effects on integrin activation.

We welcome Prof. Maria Contel and Tina Elie for their short vist to the lab. Maria is developing new metal compounds as anti-cancer drug leads.

In PLOS ONE Florian shows how an exciting new drug lead called englerin may specifically attack kidney cancer cells.

Behold! The New Cancer Center Building! Take a photo tour of the Center Here!
Florian has a paper in Oncogene revealing that in the context of oncogenic Ras, PEA-15 activates PLD and enhances transformation. See new work on PEA-15 and RSK2 listed at NLM's Pubmed. Learn more about PEA-15 at our UCSD-Nature Molecule page.
 
 

Quote

"The first principle (of scientific integrity) is that you must not fool yourself-and you are the easiest person to fool..."- Richard P. Feynman, The Pleasure of Finding Things Out.

 

Web page created and maintained by Joe W. Ramos

Revised: May 2014

2014, All rights reserved.